All News #Library
Biotech
Salubris Biotherapeutics Announces Dose Escalation Data for JK06
18 Oct 2025 //
PHARMIWEB
Salubris Biotherapeutics Updates Jk07 & Jk06 Clinical Programs
29 Sep 2025 //
BUSINESSWIRE
Salubris Announces Positive Data in JK07 Heart Failure Trial
22 Jan 2025 //
BUSINESSWIRE
Salubris Biotherapeutics` JK06 ADC Trial Approved By European Regulator
05 Aug 2024 //
BUSINESSWIRE

Market Place
Sourcing Support